國家衛生研究院 NHRI:Item 3990099045/3567

NHRI > Institute of Cellular and Systems Medicine > Chi-Ming Liang(2007-2009) > Periodical Articles > Item 3990099045/3567

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/3567

Title:	Albumin fibrillization induces apoptosis via integrin/FAK/Akt pathway
Authors:	Huang, CY;Liang, CM;Chu, CL;Liang, M
Contributors:	Institute of Cellular and Systems Medicine
Abstract:	Background: Numerous proteins can be converted to amyloid-like fibrils to increase cytotoxicity and induce apoptosis, but the methods generally require a high concentration of protein, vigorous shaking, or fibril seed. As well, the detailed mechanism of the cytotoxic effects is not well characterized. In this study, we have developed a novel process to convert native proteins into the fibrillar form. We used globular bovine serum albumin (BSA) as a model protein to verify the properties of the fibrillar protein, investigated its cellular effects and studied the signaling cascade induced by the fibrillar protein. Results: We induced BSA, a non-cytotoxic globular protein, to become fibril by a novel process involving Superdex-200 column chromatography in the presence of anionic or zwittergenic detergent(s). The column pore size was more important than column matrix composite in fibril formation. The fibrillar BSA induced apoptosis in BHK-21 cell as well as breast cancer cell line T47D. Pre-treating cells with anti-integrin antibodies blocked the apoptotic effect. Fibrillar BSA, but not globular BSA, bound to integrin, dephosphorylated focal adhesion kinase (FAK), Akt and glycogen synthase kinase-3β (GSK-3β). Conclusion: We report on a novel process for converting globular proteins into fibrillar form to cause apoptosis by modulating the integrin/FAK/Akt/GSK-3β/caspase-3 signaling pathway. Our findings may be useful for understanding the pathogenesis of amyloid-like fibrils and applicable for the development of better therapeutic agents that target the underlying mechanism(s) of the etiologic agents. ? 2009 Huang et al; licensee BioMed Central Ltd.
Date:	2009-01-08
Relation:	BMC Biotechnology. 2009 Jan 8;9:Article number 2.
Link to:	http://dx.doi.org/10.1186/1472-6750-9-2
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1472-6750&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000262698600001
Cited Times(Scopus):	http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=59449090805
Appears in Collections:	[Chi-Ming Liang(2007-2009)] Periodical Articles

Files in This Item:

File	Description	Size	Format
SCP59449090805.pdf		2183Kb	Adobe PDF	909	View/Open

Loading...